These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy. Abreu NJ; Waldrop MA Pediatr Pulmonol; 2021 Apr; 56(4):710-720. PubMed ID: 32886442 [TBL] [Abstract][Full Text] [Related]
12. Gene therapeutic strategies and relevant clinical trials in neuromuscular disorder in China. Hu C; Li X Gene Ther; 2020 Aug; 27(7-8):321-328. PubMed ID: 32591735 [TBL] [Abstract][Full Text] [Related]
13. Restoring Protein Expression in Neuromuscular Conditions: A Review Assessing the Current State of Exon Skipping/Inclusion and Gene Therapies for Duchenne Muscular Dystrophy and Spinal Muscular Atrophy. Sheikh O; Yokota T BioDrugs; 2021 Jul; 35(4):389-399. PubMed ID: 34097287 [TBL] [Abstract][Full Text] [Related]
14. Gene-based therapies for neuromuscular disorders. Zanoteli E; França MC; Marques W Arq Neuropsiquiatr; 2024 Jun; 82(6):1-10. PubMed ID: 38325390 [TBL] [Abstract][Full Text] [Related]
15. New developments in exon skipping and splice modulation therapies for neuromuscular diseases. Touznik A; Lee JJ; Yokota T Expert Opin Biol Ther; 2014 Jun; 14(6):809-19. PubMed ID: 24620745 [TBL] [Abstract][Full Text] [Related]
16. Genome engineering: a new approach to gene therapy for neuromuscular disorders. Nelson CE; Robinson-Hamm JN; Gersbach CA Nat Rev Neurol; 2017 Nov; 13(11):647-661. PubMed ID: 28960187 [TBL] [Abstract][Full Text] [Related]
17. Genetic therapies for inherited neuromuscular disorders. Scoto M; Finkel R; Mercuri E; Muntoni F Lancet Child Adolesc Health; 2018 Aug; 2(8):600-609. PubMed ID: 30119719 [TBL] [Abstract][Full Text] [Related]
18. A Historical and Current Review of Newborn Screening for Neuromuscular Disorders From Around the World: Lessons for the United States. Ross LF; Clarke AJ Pediatr Neurol; 2017 Dec; 77():12-22. PubMed ID: 29079012 [TBL] [Abstract][Full Text] [Related]
19. On the path to evidence-based therapy in neuromuscular disorders. Younger DS Handb Clin Neurol; 2023; 195():315-358. PubMed ID: 37562877 [TBL] [Abstract][Full Text] [Related]